Delivery Order SPE2DP20D0002-SPE2DP23F2844
Award Date 3/22/23
Potential Completion Date 3/28/23
Potential Value $305K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide Adenovirus Type 4. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor and will perform all work at its facility located in Parsippany, New Jersey, with work scheduled to be completed by May 23, 2023.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide adenovirus type 4 from March 22, 2023 through March 28, 2023. Teva Pharmaceuticals USA, Inc. will perform the contract from its place of performance in Parsippany, New Jersey.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide Adenovirus Type 4. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor and will perform all work at its facility located in Parsippany, New Jersey, with work scheduled to be completed by May 23, 2023.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide adenovirus type 4. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor and will perform all work at its location in Parsippany, New Jersey, with work scheduled to be completed by February 28, 2023.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $423,530.64 firm fixed price delivery order contract to provide Adenovirus Type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., is located in Parsippany, New Jersey and will perform the work at that location from December 7, 2021 through December 14, 2021.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 from January 18, 2023 through January 24, 2023. Teva Pharmaceuticals USA, Inc. will perform all work as the prime contractor at their location in Parsippany, New Jersey.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $734,119.65 firm fixed price delivery order contract to provide Adenovirus Type 4. Teva Pharmaceuticals USA, Inc. will perform all work as the prime contractor, with the place of performance listed as Parsippany, New Jersey. The period of performance for this contract is from July 18, 2022 through July 26, 2022.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2023 through April 25, 2023. Teva Pharmaceuticals USA, Inc. will perform the contract from its place of performance in Parsippany, New Jersey.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $916,181.28 firm fixed price delivery order contract to provide Adenovirus Type 4. Teva Pharmaceuticals USA, Inc. will perform all work as the prime contractor at their location in Parsippany, New Jersey, with work scheduled to be completed by July 25, 2023.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $734,119.65 firm fixed price delivery order contract to provide Adenovirus Type 4. Teva Pharmaceuticals USA, Inc. will perform all work as the prime contractor, with the place of performance listed as Parsippany, New Jersey. The period of performance for this contract is from June 14, 2022 through June 28, 2022.</p>